Medical device licence · 34841 · Class 4
AMPLILINK
No longer licensed: cancelled
Licence status Cancelled; first licensed December 17, 2001; ended May 5, 2026. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 34841
- Licence holder
- Roche Molecular Systems, IncBranchburg, NJ, United States
- Risk class
- Class IV (highest risk)
- Licence type
- Device Family
- First licensed
- December 17, 2001
- Ended
- May 5, 2026
- Devices covered
- 18
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- AMPLILINK SOFTWARE V 3.2
- AMPLILINK SOFTWARE V 3.2.3
- AMPLILINK SOFTWARE V. 3.0.1
- AMPLILINK SOFTWARE V. 3.2.2
- AMPLILINK SOFTWARE VERSION 1.4
- AMPLILINK SOFTWARE VERSION 2.3
- AMPLILINK SOFTWARE VERSION 2.41
- AMPLILINK SOFTWARE VERSION 3.1.1
- AMPLILINK SOFTWARE VERSION 3.1.2 BUILD 0502
- AMPLILINK SOFTWARE VERSION 3.2.1
- AMPLILINK SOFTWARE VERSION 3.3.2
- AMPLILINK SOFTWARE VERSION 3.3.3
- AMPLILINK SOFTWARE VERSION 3.3.5
- AMPLILINK SOFTWARE VERSION 3.3.6
- AMPLILINK SOFTWARE VERSION 3.3.7
- AMPLILINK SOFTWARE VERSION 3.4.0
- AMPLILINK V. 1.3
- AMPLILINK V2.42 SOFTWARE (BRIDGE)
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.